|
Volumn 30, Issue 8, 1998, Pages 4115-4121
|
Selective immunotherapy of IDDM: A discussion based on new findings from the RIP-LCMV model for autoimmune diabetes
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIGEN;
CD3 ANTIGEN;
CD40 ANTIGEN;
CYTOKINE;
LIGAND;
PEPTIDE;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTIGEN PRESENTATION;
AUTOIMMUNE DISEASE;
CONFERENCE PAPER;
ENVIRONMENTAL FACTOR;
HELPER CELL;
HOST RESISTANCE;
IMMUNOMODULATION;
IMMUNOSUPPRESSIVE TREATMENT;
IMMUNOTHERAPY;
INSULIN DEPENDENT DIABETES MELLITUS;
LYMPHOCYTE ACTIVATION;
MOUSE;
NONHUMAN;
PANCREAS ISLET CELL;
PATHOGENESIS;
PRIORITY JOURNAL;
ANIMALS;
DIABETES MELLITUS, TYPE 1;
DISEASE MODELS, ANIMAL;
HUMANS;
IMMUNOTHERAPY;
INSULIN;
ISLETS OF LANGERHANS;
LYMPHOCYTIC CHORIOMENINGITIS VIRUS;
MICE;
MICE, TRANSGENIC;
MODELS, IMMUNOLOGICAL;
PROMOTER REGIONS (GENETICS);
RATS;
|
EID: 0032410767
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(98)01362-1 Document Type: Conference Paper |
Times cited : (4)
|
References (122)
|